menu search

Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
Live video webcast panel presentation on Tuesday, September 26th at 1:35 PM ET ISELIN, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced that Russell Trenary, President and CEO […] The post Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference appeared first on... Read More
Posted: Sep 21 2023, 12:05
Author Name: forextv
Views: 102087

Search within

Pages Search Results: